The market turbulence unleashed by President Donald Trump’s tariff policies will likely evaporate the trickle of biotech IPOs ...

It was only yesterday that BlackRock CEO Larry Fink said that “we’re probably in a recession” right now. Most investors ...

Bank of America Securities analyst Tim Anderson reiterated a Buy rating on Metsera, Inc. (MTSR – Research Report) today and set a price target ...

Despite several big deals that buoyed the numbers, North America early- and seed-stage investment declined to multiquarter ...